

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication-dependent nucleosome assembly (GO:0006335) | 9.47782538 |
| 2 | DNA replication-dependent nucleosome organization (GO:0034723) | 9.47782538 |
| 3 | chromatin assembly (GO:0031497) | 8.30926224 |
| 4 | regulation of histone H3-K9 methylation (GO:0051570) | 7.68449688 |
| 5 | nucleosome assembly (GO:0006334) | 7.38760408 |
| 6 | nucleosome organization (GO:0034728) | 6.35188352 |
| 7 | nuclear pore complex assembly (GO:0051292) | 6.24340770 |
| 8 | protein-DNA complex assembly (GO:0065004) | 6.22358563 |
| 9 | protein neddylation (GO:0045116) | 6.18265818 |
| 10 | nuclear pore organization (GO:0006999) | 6.11137940 |
| 11 | chromatin assembly or disassembly (GO:0006333) | 5.96068797 |
| 12 | DNA unwinding involved in DNA replication (GO:0006268) | 5.94550077 |
| 13 | antibacterial humoral response (GO:0019731) | 5.66983602 |
| 14 | protein-DNA complex subunit organization (GO:0071824) | 5.53645958 |
| 15 | mitotic chromosome condensation (GO:0007076) | 5.52034468 |
| 16 | innate immune response in mucosa (GO:0002227) | 5.46582712 |
| 17 | protein localization to kinetochore (GO:0034501) | 5.42887777 |
| 18 | thrombin receptor signaling pathway (GO:0070493) | 5.35039796 |
| 19 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.29515389 |
| 20 | antimicrobial humoral response (GO:0019730) | 5.26892208 |
| 21 | sister chromatid segregation (GO:0000819) | 5.19676789 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.98343188 |
| 23 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.97875212 |
| 24 | protein localization to chromosome, centromeric region (GO:0071459) | 4.74866796 |
| 25 | regulation of megakaryocyte differentiation (GO:0045652) | 4.72583243 |
| 26 | pore complex assembly (GO:0046931) | 4.69434521 |
| 27 | mitotic sister chromatid segregation (GO:0000070) | 4.55028089 |
| 28 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.50879735 |
| 29 | DNA replication initiation (GO:0006270) | 4.40898212 |
| 30 | negative regulation of histone methylation (GO:0031061) | 4.40740505 |
| 31 | platelet aggregation (GO:0070527) | 4.38676924 |
| 32 | chromatin remodeling at centromere (GO:0031055) | 4.31525924 |
| 33 | CENP-A containing nucleosome assembly (GO:0034080) | 4.28442816 |
| 34 | mucosal immune response (GO:0002385) | 4.16812965 |
| 35 | regulation of platelet aggregation (GO:0090330) | 4.16222234 |
| 36 | DNA duplex unwinding (GO:0032508) | 4.08121626 |
| 37 | DNA geometric change (GO:0032392) | 4.06883710 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.02729724 |
| 39 | regulation of gene silencing (GO:0060968) | 4.01498654 |
| 40 | positive regulation of chromosome segregation (GO:0051984) | 4.01465628 |
| 41 | protein K6-linked ubiquitination (GO:0085020) | 3.98612183 |
| 42 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.95479139 |
| 43 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.94811245 |
| 44 | organ or tissue specific immune response (GO:0002251) | 3.93130633 |
| 45 | regulation of sister chromatid cohesion (GO:0007063) | 3.92909540 |
| 46 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.90112081 |
| 47 | DNA replication-independent nucleosome organization (GO:0034724) | 3.90112081 |
| 48 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.89121068 |
| 49 | mitotic nuclear envelope disassembly (GO:0007077) | 3.89047980 |
| 50 | translesion synthesis (GO:0019985) | 3.88507673 |
| 51 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.88373810 |
| 52 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.88373810 |
| 53 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.88373810 |
| 54 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87262600 |
| 55 | chromosome condensation (GO:0030261) | 3.86668137 |
| 56 | mitotic sister chromatid cohesion (GO:0007064) | 3.85785751 |
| 57 | dosage compensation (GO:0007549) | 3.82781238 |
| 58 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.81307957 |
| 59 | regulation of centriole replication (GO:0046599) | 3.80282118 |
| 60 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.78795123 |
| 61 | regulation of gene silencing by miRNA (GO:0060964) | 3.78795123 |
| 62 | regulation of gene silencing by RNA (GO:0060966) | 3.78795123 |
| 63 | adenosine receptor signaling pathway (GO:0001973) | 3.76842217 |
| 64 | defense response to Gram-positive bacterium (GO:0050830) | 3.76043866 |
| 65 | regulation of platelet activation (GO:0010543) | 3.74947143 |
| 66 | DNA strand elongation (GO:0022616) | 3.73104698 |
| 67 | kinetochore organization (GO:0051383) | 3.72973169 |
| 68 | polyamine biosynthetic process (GO:0006596) | 3.71247451 |
| 69 | membrane disassembly (GO:0030397) | 3.71075470 |
| 70 | nuclear envelope disassembly (GO:0051081) | 3.71075470 |
| 71 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.70187003 |
| 72 | positive regulation of histone methylation (GO:0031062) | 3.69591503 |
| 73 | negative regulation of norepinephrine secretion (GO:0010700) | 3.69313098 |
| 74 | megakaryocyte development (GO:0035855) | 3.68872270 |
| 75 | regulation of integrin activation (GO:0033623) | 3.68097964 |
| 76 | mitotic recombination (GO:0006312) | 3.66558101 |
| 77 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.64603650 |
| 78 | DNA topological change (GO:0006265) | 3.63265813 |
| 79 | microtubule depolymerization (GO:0007019) | 3.63139136 |
| 80 | histone exchange (GO:0043486) | 3.60240656 |
| 81 | IMP biosynthetic process (GO:0006188) | 3.57703573 |
| 82 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.54436224 |
| 83 | regulation of centrosome cycle (GO:0046605) | 3.53948400 |
| 84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.53129584 |
| 85 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.51830985 |
| 86 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.51570183 |
| 87 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.51420725 |
| 88 | pre-miRNA processing (GO:0031054) | 3.46380470 |
| 89 | postreplication repair (GO:0006301) | 3.45639041 |
| 90 | regulation of DNA endoreduplication (GO:0032875) | 3.43603695 |
| 91 | B cell mediated immunity (GO:0019724) | 3.43059060 |
| 92 | regulation of translational fidelity (GO:0006450) | 3.40869824 |
| 93 | regulation of chromosome segregation (GO:0051983) | 3.40633610 |
| 94 | DNA conformation change (GO:0071103) | 3.40464176 |
| 95 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.37000695 |
| 96 | meiotic chromosome segregation (GO:0045132) | 3.36904902 |
| 97 | mitochondrial calcium ion transport (GO:0006851) | 3.36547478 |
| 98 | lipoxygenase pathway (GO:0019372) | 3.34952271 |
| 99 | platelet formation (GO:0030220) | 3.33996967 |
| 100 | DNA packaging (GO:0006323) | 3.33088266 |
| 101 | telomere maintenance via recombination (GO:0000722) | 3.31314373 |
| 102 | regulation of RNA export from nucleus (GO:0046831) | 3.28226034 |
| 103 | regulation of centrosome duplication (GO:0010824) | 3.27566603 |
| 104 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.25750933 |
| 105 | regulation of helicase activity (GO:0051095) | 3.24896507 |
| 106 | DNA synthesis involved in DNA repair (GO:0000731) | 3.23391288 |
| 107 | protein localization to chromosome (GO:0034502) | 3.20755505 |
| 108 | spindle checkpoint (GO:0031577) | 3.20466747 |
| 109 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.18758228 |
| 110 | B cell receptor signaling pathway (GO:0050853) | 3.18659947 |
| 111 | regulation of spindle organization (GO:0090224) | 3.18618698 |
| 112 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.17704203 |
| 113 | ATP-dependent chromatin remodeling (GO:0043044) | 3.17548375 |
| 114 | positive regulation of macrophage differentiation (GO:0045651) | 3.16435114 |
| 115 | regulation of histone methylation (GO:0031060) | 3.16245240 |
| 116 | IMP metabolic process (GO:0046040) | 3.16029639 |
| 117 | negative regulation of DNA repair (GO:0045738) | 3.14389589 |
| 118 | chromosome segregation (GO:0007059) | 3.12999187 |
| 119 | histone lysine demethylation (GO:0070076) | 3.11067782 |
| 120 | spindle assembly checkpoint (GO:0071173) | 3.10868681 |
| 121 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.10532131 |
| 122 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.10391194 |
| 123 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.09992325 |
| 124 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.08773522 |
| 125 | mitotic metaphase plate congression (GO:0007080) | 3.06222116 |
| 126 | negative regulation of T cell apoptotic process (GO:0070233) | 3.05614131 |
| 127 | telomere maintenance (GO:0000723) | 3.04935844 |
| 128 | histone demethylation (GO:0016577) | 3.03152454 |
| 129 | immunoglobulin mediated immune response (GO:0016064) | 3.02626270 |
| 130 | regulation of sister chromatid segregation (GO:0033045) | 3.01806224 |
| 131 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.01806224 |
| 132 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.01806224 |
| 133 | negative regulation of platelet activation (GO:0010544) | 3.01455116 |
| 134 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.00078332 |
| 135 | homotypic cell-cell adhesion (GO:0034109) | 2.99967807 |
| 136 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.99044175 |
| 137 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.94662737 |
| 138 | regulation of endothelial cell differentiation (GO:0045601) | 2.92915719 |
| 139 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.91555901 |
| 140 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.91301887 |
| 141 | regulation of thymocyte apoptotic process (GO:0070243) | 2.84669112 |
| 142 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.84650283 |
| 143 | platelet degranulation (GO:0002576) | 2.84491849 |
| 144 | positive regulation of mast cell activation (GO:0033005) | 2.79481316 |
| 145 | angiogenesis involved in wound healing (GO:0060055) | 2.72427041 |
| 146 | positive regulation of B cell mediated immunity (GO:0002714) | 2.67281150 |
| 147 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.67281150 |
| 148 | negative regulation of heart rate (GO:0010459) | 2.66767831 |
| 149 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66600309 |
| 150 | platelet activation (GO:0030168) | 2.66576940 |
| 151 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.66479970 |
| 152 | regulation of hematopoietic progenitor cell differentiation (GO:1901532) | 2.65929824 |
| 153 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.64603030 |
| 154 | low-density lipoprotein particle remodeling (GO:0034374) | 2.59827466 |
| 155 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57687880 |
| 156 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.56871854 |
| 157 | positive regulation of B cell differentiation (GO:0045579) | 2.56418958 |
| 158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.56222266 |
| 159 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.54805338 |
| 160 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.49774431 |
| 161 | neutrophil activation (GO:0042119) | 2.48428159 |
| 162 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.46676876 |
| 163 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.46676876 |
| 164 | proline biosynthetic process (GO:0006561) | 2.46588407 |
| 165 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.46372538 |
| 166 | purinergic receptor signaling pathway (GO:0035587) | 2.45848384 |
| 167 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.45325575 |
| 168 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.44730906 |
| 169 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.42678889 |
| 170 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38712682 |
| 171 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.38533324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.98275128 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.66687094 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.40181690 |
| 4 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.22883179 |
| 5 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 3.32203921 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.23009954 |
| 7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.44748118 |
| 8 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37265274 |
| 9 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.33475062 |
| 10 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 2.16372374 |
| 11 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.14009068 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11380308 |
| 13 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.11195623 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 15.9300654 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.95249119 |
| 16 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88729406 |
| 17 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.87857992 |
| 18 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.86107148 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.80374708 |
| 20 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.79234341 |
| 21 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.76102074 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.69844828 |
| 23 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.69809983 |
| 24 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65057564 |
| 25 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64743654 |
| 26 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.63796745 |
| 27 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.58381419 |
| 28 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.51881335 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.51375189 |
| 30 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.46665333 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45995692 |
| 32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45662675 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42911594 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.40071132 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37744600 |
| 36 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37180299 |
| 37 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.35281612 |
| 38 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33906469 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.31719285 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30443229 |
| 41 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.27707753 |
| 42 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26436179 |
| 43 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26435593 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25169512 |
| 45 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25079749 |
| 46 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23963538 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21595688 |
| 48 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21237207 |
| 49 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21157643 |
| 50 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20464401 |
| 51 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19492647 |
| 52 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.15889522 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15175807 |
| 54 | * MAF_26560356_Chip-Seq_TH1_Human | 1.14368889 |
| 55 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.13346388 |
| 56 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.12966970 |
| 57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12176079 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09182808 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08141153 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06169924 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04955861 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.02927714 |
| 63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.02204884 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00774918 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00176187 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97741544 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97487145 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97197538 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97086463 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95907437 |
| 71 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94741299 |
| 72 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93799966 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 0.93251966 |
| 74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90828308 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89790405 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89144878 |
| 77 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87382578 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87255558 |
| 79 | MYB_26560356_Chip-Seq_TH2_Human | 0.87102226 |
| 80 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.86926371 |
| 81 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86509987 |
| 82 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.85565291 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85301763 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84149363 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.83600121 |
| 86 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.83233191 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.82898703 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82892064 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.82749649 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82070946 |
| 91 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.81812648 |
| 92 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.81404385 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81012701 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80485343 |
| 95 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.78520346 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77637331 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.77446037 |
| 98 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76490737 |
| 99 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.76216845 |
| 100 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75211980 |
| 101 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.74642164 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.73992684 |
| 103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73891272 |
| 104 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.72378947 |
| 105 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.72361753 |
| 106 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.72138788 |
| 107 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.71850046 |
| 108 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.71795188 |
| 109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71775964 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71037682 |
| 111 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70685372 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70312134 |
| 113 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.69898108 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.69881185 |
| 115 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.69561727 |
| 116 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68248738 |
| 117 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67403430 |
| 118 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.66732581 |
| 119 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.66663899 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.65284833 |
| 121 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.64459892 |
| 122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.63172917 |
| 123 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.62411598 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.60847213 |
| 125 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.60660046 |
| 126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.60580895 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60564448 |
| 128 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.58098460 |
| 129 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.57692223 |
| 130 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.57616033 |
| 131 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.56192651 |
| 132 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.55033042 |
| 133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.54942143 |
| 134 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.53921604 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.53423499 |
| 136 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.53212191 |
| 137 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.52363364 |
| 138 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.52003221 |
| 139 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.51669264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 7.56826866 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.90172362 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.34554690 |
| 4 | MP0010307_abnormal_tumor_latency | 3.91709815 |
| 5 | MP0003077_abnormal_cell_cycle | 3.69563201 |
| 6 | MP0008004_abnormal_stomach_pH | 3.59905547 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.35535840 |
| 8 | MP0008057_abnormal_DNA_replication | 3.15778098 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 3.10258973 |
| 10 | MP0001835_abnormal_antigen_presentation | 3.07751940 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 3.03162283 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.90612336 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.68291263 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.66154343 |
| 15 | MP0004147_increased_porphyrin_level | 2.65002157 |
| 16 | MP0005671_abnormal_response_to | 2.57305511 |
| 17 | MP0003123_paternal_imprinting | 2.57214261 |
| 18 | MP0003121_genomic_imprinting | 2.51319365 |
| 19 | MP0000685_abnormal_immune_system | 2.46884594 |
| 20 | MP0008058_abnormal_DNA_repair | 2.41064157 |
| 21 | MP0005076_abnormal_cell_differentiation | 2.36253237 |
| 22 | MP0000350_abnormal_cell_proliferation | 2.30927574 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 2.27399981 |
| 24 | MP0001730_embryonic_growth_arrest | 2.26768305 |
| 25 | MP0008007_abnormal_cellular_replicative | 2.17790535 |
| 26 | MP0008932_abnormal_embryonic_tissue | 2.15503470 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 2.14500795 |
| 28 | MP0003303_peritoneal_inflammation | 2.09703986 |
| 29 | MP0009697_abnormal_copulation | 2.08628229 |
| 30 | MP0008877_abnormal_DNA_methylation | 2.05060651 |
| 31 | MP0003763_abnormal_thymus_physiology | 2.03634282 |
| 32 | MP0001800_abnormal_humoral_immune | 2.01276560 |
| 33 | MP0003724_increased_susceptibility_to | 1.97535040 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.96113860 |
| 35 | MP0004197_abnormal_fetal_growth/weight/ | 1.95250773 |
| 36 | MP0000537_abnormal_urethra_morphology | 1.94785892 |
| 37 | MP0002084_abnormal_developmental_patter | 1.87953164 |
| 38 | MP0002086_abnormal_extraembryonic_tissu | 1.83960811 |
| 39 | MP0001697_abnormal_embryo_size | 1.82353676 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.76861985 |
| 41 | MP0005380_embryogenesis_phenotype | 1.76861985 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.74679362 |
| 43 | MP0002085_abnormal_embryonic_tissue | 1.74394515 |
| 44 | MP0006054_spinal_hemorrhage | 1.69777582 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.67171287 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.67151837 |
| 47 | MP0002429_abnormal_blood_cell | 1.62057895 |
| 48 | MP0002080_prenatal_lethality | 1.59950736 |
| 49 | MP0002723_abnormal_immune_serum | 1.56806183 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.56543096 |
| 51 | MP0001661_extended_life_span | 1.56017978 |
| 52 | MP0003984_embryonic_growth_retardation | 1.53657693 |
| 53 | MP0003937_abnormal_limbs/digits/tail_de | 1.52182399 |
| 54 | MP0000490_abnormal_crypts_of | 1.51822452 |
| 55 | MP0002088_abnormal_embryonic_growth/wei | 1.51612617 |
| 56 | MP0000343_altered_response_to | 1.51348384 |
| 57 | MP0003787_abnormal_imprinting | 1.50842099 |
| 58 | MP0005387_immune_system_phenotype | 1.48004014 |
| 59 | MP0001790_abnormal_immune_system | 1.48004014 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.44983894 |
| 61 | MP0000716_abnormal_immune_system | 1.43874618 |
| 62 | MP0004510_myositis | 1.43727182 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.42034486 |
| 64 | MP0001819_abnormal_immune_cell | 1.40656440 |
| 65 | MP0003786_premature_aging | 1.40091458 |
| 66 | MP0004947_skin_inflammation | 1.40042982 |
| 67 | MP0002009_preneoplasia | 1.37451791 |
| 68 | MP0001293_anophthalmia | 1.31804555 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.30693953 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.29896479 |
| 71 | MP0000313_abnormal_cell_death | 1.26076613 |
| 72 | MP0000358_abnormal_cell_content/ | 1.25441559 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 1.24693850 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 1.24548501 |
| 75 | MP0010030_abnormal_orbit_morphology | 1.22918136 |
| 76 | MP0001879_abnormal_lymphatic_vessel | 1.22151440 |
| 77 | MP0002111_abnormal_tail_morphology | 1.21659584 |
| 78 | MP0003890_abnormal_embryonic-extraembry | 1.20793788 |
| 79 | MP0009053_abnormal_anal_canal | 1.19665923 |
| 80 | MP0002092_abnormal_eye_morphology | 1.19076026 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 1.18877001 |
| 82 | MP0000733_abnormal_muscle_development | 1.18756972 |
| 83 | MP0002697_abnormal_eye_size | 1.18591028 |
| 84 | MP0005410_abnormal_fertilization | 1.17663547 |
| 85 | MP0009703_decreased_birth_body | 1.13888534 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 1.13887816 |
| 87 | MP0005083_abnormal_biliary_tract | 1.13167909 |
| 88 | MP0002132_abnormal_respiratory_system | 1.13060481 |
| 89 | MP0000703_abnormal_thymus_morphology | 1.11247002 |
| 90 | MP0003283_abnormal_digestive_organ | 1.09978848 |
| 91 | MP0009672_abnormal_birth_weight | 1.08727946 |
| 92 | MP0008770_decreased_survivor_rate | 1.04611472 |
| 93 | MP0003119_abnormal_digestive_system | 1.04598560 |
| 94 | MP0001915_intracranial_hemorrhage | 1.04326031 |
| 95 | MP0000858_altered_metastatic_potential | 1.03010175 |
| 96 | MP0000015_abnormal_ear_pigmentation | 1.01780202 |
| 97 | MP0001845_abnormal_inflammatory_respons | 1.01586684 |
| 98 | MP0000428_abnormal_craniofacial_morphol | 1.01164062 |
| 99 | MP0008872_abnormal_physiological_respon | 1.00491868 |
| 100 | MP0009763_increased_sensitivity_to | 0.99790821 |
| 101 | MP0005025_abnormal_response_to | 0.98558224 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97951704 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.97818005 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.97685685 |
| 105 | MP0003436_decreased_susceptibility_to | 0.97222710 |
| 106 | MP0001851_eye_inflammation | 0.95629783 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.94697423 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.93980528 |
| 109 | MP0003861_abnormal_nervous_system | 0.91937620 |
| 110 | MP0008260_abnormal_autophagy | 0.91663115 |
| 111 | MP0003115_abnormal_respiratory_system | 0.90670527 |
| 112 | MP0009764_decreased_sensitivity_to | 0.90233917 |
| 113 | MP0002722_abnormal_immune_system | 0.88829627 |
| 114 | MP0010678_abnormal_skin_adnexa | 0.87472645 |
| 115 | MP0002925_abnormal_cardiovascular_devel | 0.87130915 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.86615605 |
| 117 | MP0000249_abnormal_blood_vessel | 0.86087948 |
| 118 | MP0005187_abnormal_penis_morphology | 0.83834949 |
| 119 | MP0002736_abnormal_nociception_after | 0.83597054 |
| 120 | MP0003828_pulmonary_edema | 0.83498778 |
| 121 | MP0002398_abnormal_bone_marrow | 0.82975367 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.81753444 |
| 123 | MP0001663_abnormal_digestive_system | 0.81707493 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.81446936 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.79399870 |
| 126 | MP0001145_abnormal_male_reproductive | 0.78697027 |
| 127 | MP0005621_abnormal_cell_physiology | 0.78088783 |
| 128 | MP0005647_abnormal_sex_gland | 0.77983356 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.77982300 |
| 130 | MP0005384_cellular_phenotype | 0.77861146 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.77851541 |
| 132 | MP0004130_abnormal_muscle_cell | 0.77780813 |
| 133 | MP0001286_abnormal_eye_development | 0.77587965 |
| 134 | MP0002210_abnormal_sex_determination | 0.77249947 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.76576263 |
| 136 | MP0001849_ear_inflammation | 0.76415035 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.76371054 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.75011344 |
| 139 | MP0001929_abnormal_gametogenesis | 0.74354019 |
| 140 | MP0005310_abnormal_salivary_gland | 0.73426087 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.73137286 |
| 142 | MP0000432_abnormal_head_morphology | 0.72936031 |
| 143 | MP0005023_abnormal_wound_healing | 0.72884625 |
| 144 | MP0002419_abnormal_innate_immunity | 0.72574122 |
| 145 | MP0004233_abnormal_muscle_weight | 0.72300951 |
| 146 | MP0002006_tumorigenesis | 0.71662329 |
| 147 | MP0003935_abnormal_craniofacial_develop | 0.68506756 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.68174244 |
| 149 | MP0003300_gastrointestinal_ulcer | 0.67391789 |
| 150 | MP0009278_abnormal_bone_marrow | 0.66963865 |
| 151 | MP0006072_abnormal_retinal_apoptosis | 0.66614164 |
| 152 | MP0000266_abnormal_heart_morphology | 0.65133315 |
| 153 | MP0000653_abnormal_sex_gland | 0.64617056 |
| 154 | MP0005501_abnormal_skin_physiology | 0.64417841 |
| 155 | MP0003718_maternal_effect | 0.64095377 |
| 156 | MP0003941_abnormal_skin_development | 0.63489629 |
| 157 | MP0004272_abnormal_basement_membrane | 0.63482153 |
| 158 | MP0002282_abnormal_trachea_morphology | 0.62449749 |
| 159 | MP0000462_abnormal_digestive_system | 0.62419240 |
| 160 | MP0000477_abnormal_intestine_morphology | 0.61199266 |
| 161 | MP0005397_hematopoietic_system_phenotyp | 0.60531002 |
| 162 | MP0001545_abnormal_hematopoietic_system | 0.60531002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.63719161 |
| 2 | Increased mean platelet volume (HP:0011877) | 8.48070465 |
| 3 | Abnormal platelet volume (HP:0011876) | 8.16244503 |
| 4 | Petechiae (HP:0000967) | 8.13909837 |
| 5 | Menorrhagia (HP:0000132) | 7.71838150 |
| 6 | Purpura (HP:0000979) | 6.88391849 |
| 7 | Epistaxis (HP:0000421) | 5.89248464 |
| 8 | Poikilocytosis (HP:0004447) | 5.10097309 |
| 9 | Abnormal platelet function (HP:0011869) | 4.76675974 |
| 10 | Impaired platelet aggregation (HP:0003540) | 4.76675974 |
| 11 | Gingival bleeding (HP:0000225) | 4.63290776 |
| 12 | IgA deficiency (HP:0002720) | 4.42233598 |
| 13 | Spontaneous hematomas (HP:0007420) | 3.93358562 |
| 14 | IgM deficiency (HP:0002850) | 3.85739025 |
| 15 | Dyschromatopsia (HP:0007641) | 3.81048402 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.77774351 |
| 17 | Acanthocytosis (HP:0001927) | 3.71284876 |
| 18 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.52724131 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 3.49939680 |
| 20 | Chromsome breakage (HP:0040012) | 3.47315494 |
| 21 | Hypochromic microcytic anemia (HP:0004840) | 3.42534400 |
| 22 | Paralysis (HP:0003470) | 3.38342000 |
| 23 | Medulloblastoma (HP:0002885) | 3.32364791 |
| 24 | Reticulocytosis (HP:0001923) | 3.25510423 |
| 25 | Impulsivity (HP:0100710) | 3.25056026 |
| 26 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.24434758 |
| 27 | Short 4th metacarpal (HP:0010044) | 3.24434758 |
| 28 | Ependymoma (HP:0002888) | 3.17282479 |
| 29 | Abnormality of reticulocytes (HP:0004312) | 3.15349777 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.13129874 |
| 31 | Colon cancer (HP:0003003) | 3.12625240 |
| 32 | Abnormality of chromosome stability (HP:0003220) | 3.11754652 |
| 33 | Conjunctival telangiectasia (HP:0000524) | 3.09888107 |
| 34 | Abnormality of the astrocytes (HP:0100707) | 3.08712730 |
| 35 | Astrocytoma (HP:0009592) | 3.08712730 |
| 36 | Volvulus (HP:0002580) | 2.99422316 |
| 37 | Reticulocytopenia (HP:0001896) | 2.97286405 |
| 38 | Colitis (HP:0002583) | 2.90079737 |
| 39 | Cutaneous melanoma (HP:0012056) | 2.84382185 |
| 40 | Selective tooth agenesis (HP:0001592) | 2.72047649 |
| 41 | Glioma (HP:0009733) | 2.71698657 |
| 42 | Increased density of long bones (HP:0006392) | 2.67831216 |
| 43 | Recurrent sinusitis (HP:0011108) | 2.64784590 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.64355683 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.63675884 |
| 46 | Abnormality of the labia minora (HP:0012880) | 2.61273372 |
| 47 | Rhabdomyosarcoma (HP:0002859) | 2.60740168 |
| 48 | Increased IgM level (HP:0003496) | 2.59312239 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.56560908 |
| 50 | Neoplasm of the oral cavity (HP:0100649) | 2.56344547 |
| 51 | Agnosia (HP:0010524) | 2.55645052 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.53907041 |
| 53 | Cafe-au-lait spot (HP:0000957) | 2.51107322 |
| 54 | Basal cell carcinoma (HP:0002671) | 2.50212598 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.49895732 |
| 56 | Increased nuchal translucency (HP:0010880) | 2.49546794 |
| 57 | Abnormality of lateral ventricle (HP:0030047) | 2.45899841 |
| 58 | Cellulitis (HP:0100658) | 2.45634359 |
| 59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.45439141 |
| 60 | Leiomyosarcoma (HP:0100243) | 2.44879877 |
| 61 | Uterine leiomyosarcoma (HP:0002891) | 2.44879877 |
| 62 | Birth length less than 3rd percentile (HP:0003561) | 2.42806177 |
| 63 | High pitched voice (HP:0001620) | 2.41610611 |
| 64 | Insomnia (HP:0100785) | 2.40593775 |
| 65 | Sandal gap (HP:0001852) | 2.40018878 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.36870124 |
| 67 | Lymphopenia (HP:0001888) | 2.35052059 |
| 68 | Ulnar bowing (HP:0003031) | 2.33630917 |
| 69 | Tinnitus (HP:0000360) | 2.32140361 |
| 70 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.31979132 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.31312528 |
| 72 | Small intestinal stenosis (HP:0012848) | 2.29782767 |
| 73 | Duodenal stenosis (HP:0100867) | 2.29782767 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26884156 |
| 75 | Deviation of the thumb (HP:0009603) | 2.26580232 |
| 76 | Meckel diverticulum (HP:0002245) | 2.26507473 |
| 77 | Dysautonomia (HP:0002459) | 2.25792155 |
| 78 | Cortical dysplasia (HP:0002539) | 2.25277823 |
| 79 | Bruising susceptibility (HP:0000978) | 2.25180725 |
| 80 | Abnormality of the 4th metacarpal (HP:0010012) | 2.24768045 |
| 81 | Upper limb muscle weakness (HP:0003484) | 2.22413906 |
| 82 | Gastrointestinal carcinoma (HP:0002672) | 2.21390149 |
| 83 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.21390149 |
| 84 | Lymphoma (HP:0002665) | 2.21060569 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.20856448 |
| 86 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20644441 |
| 87 | Heterotopia (HP:0002282) | 2.20427799 |
| 88 | Abnormality of macrophages (HP:0004311) | 2.20284896 |
| 89 | Abnormal pupillary function (HP:0007686) | 2.20238310 |
| 90 | Proximal placement of thumb (HP:0009623) | 2.18062652 |
| 91 | Prominent nose (HP:0000448) | 2.18057843 |
| 92 | Renovascular hypertension (HP:0100817) | 2.18021277 |
| 93 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16192609 |
| 94 | Obstructive lung disease (HP:0006536) | 2.16192609 |
| 95 | Erythema (HP:0010783) | 2.16175956 |
| 96 | Abnormality of the ileum (HP:0001549) | 2.16040327 |
| 97 | Eczematoid dermatitis (HP:0000976) | 2.14332721 |
| 98 | IgG deficiency (HP:0004315) | 2.13908018 |
| 99 | Cholecystitis (HP:0001082) | 2.11702390 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 2.11702390 |
| 101 | Biliary tract neoplasm (HP:0100574) | 2.11576687 |
| 102 | Absent frontal sinuses (HP:0002688) | 2.10752520 |
| 103 | Neoplasm of striated muscle (HP:0009728) | 2.08894531 |
| 104 | Sloping forehead (HP:0000340) | 2.07627602 |
| 105 | Hypopigmentation of the fundus (HP:0007894) | 2.07612790 |
| 106 | Abnormality of the carotid arteries (HP:0005344) | 2.07411973 |
| 107 | Recurrent viral infections (HP:0004429) | 2.06600531 |
| 108 | Meningitis (HP:0001287) | 2.06236668 |
| 109 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.04022193 |
| 110 | Spastic diplegia (HP:0001264) | 2.03192151 |
| 111 | Abnormal auditory evoked potentials (HP:0006958) | 2.01599348 |
| 112 | Myelodysplasia (HP:0002863) | 2.01397179 |
| 113 | Ectopic kidney (HP:0000086) | 2.01164677 |
| 114 | Subacute progressive viral hepatitis (HP:0006572) | 2.00334640 |
| 115 | Bladder neoplasm (HP:0009725) | 1.98802288 |
| 116 | Bladder carcinoma (HP:0002862) | 1.98802288 |
| 117 | Macrocytic anemia (HP:0001972) | 1.97990018 |
| 118 | Abnormality of the fingertips (HP:0001211) | 1.97670501 |
| 119 | 11 pairs of ribs (HP:0000878) | 1.96662809 |
| 120 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94438686 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.94181534 |
| 122 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.93896809 |
| 123 | Abnormality of the preputium (HP:0100587) | 1.93305106 |
| 124 | Abnormality of the duodenum (HP:0002246) | 1.92736583 |
| 125 | Squamous cell carcinoma (HP:0002860) | 1.92181521 |
| 126 | Missing ribs (HP:0000921) | 1.91309160 |
| 127 | Abnormality of T cell physiology (HP:0011840) | 1.90806269 |
| 128 | Patellar aplasia (HP:0006443) | 1.90011741 |
| 129 | Abnormality of chromosome segregation (HP:0002916) | 1.90002410 |
| 130 | Encephalitis (HP:0002383) | 1.89601161 |
| 131 | Papillary thyroid carcinoma (HP:0002895) | 1.89246239 |
| 132 | Abnormal lung lobation (HP:0002101) | 1.89048884 |
| 133 | Freckling (HP:0001480) | 1.88896835 |
| 134 | Orthostatic hypotension (HP:0001278) | 1.88833025 |
| 135 | Emphysema (HP:0002097) | 1.87341734 |
| 136 | Abnormal number of erythroid precursors (HP:0012131) | 1.87110976 |
| 137 | Osteomalacia (HP:0002749) | 1.86872572 |
| 138 | High anterior hairline (HP:0009890) | 1.86488708 |
| 139 | Atresia of the external auditory canal (HP:0000413) | 1.85693358 |
| 140 | Intestinal polyposis (HP:0200008) | 1.83732924 |
| 141 | Hyperacusis (HP:0010780) | 1.82880984 |
| 142 | Absent radius (HP:0003974) | 1.82827766 |
| 143 | Vasculitis (HP:0002633) | 1.82764317 |
| 144 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.82597572 |
| 145 | Recurrent bronchitis (HP:0002837) | 1.82440269 |
| 146 | Renal duplication (HP:0000075) | 1.81994653 |
| 147 | Joint swelling (HP:0001386) | 1.81368866 |
| 148 | Ovarian neoplasm (HP:0100615) | 1.81169993 |
| 149 | Intestinal polyp (HP:0005266) | 1.80986527 |
| 150 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.79709818 |
| 151 | Absent thumb (HP:0009777) | 1.79357527 |
| 152 | Increased serum ferritin (HP:0003281) | 1.77834680 |
| 153 | B lymphocytopenia (HP:0010976) | 1.76797871 |
| 154 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76523332 |
| 155 | Acute hepatic failure (HP:0006554) | 1.76178610 |
| 156 | Abnormality of B cell number (HP:0010975) | 1.75679303 |
| 157 | Ridged nail (HP:0001807) | 1.75174717 |
| 158 | Truncal obesity (HP:0001956) | 1.75134866 |
| 159 | Skull defect (HP:0001362) | 1.74989879 |
| 160 | Osteomyelitis (HP:0002754) | 1.74538414 |
| 161 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74502683 |
| 162 | Abnormal number of incisors (HP:0011064) | 1.73967389 |
| 163 | Neoplasm of the pancreas (HP:0002894) | 1.73625545 |
| 164 | Chronic diarrhea (HP:0002028) | 1.73285394 |
| 165 | Fibrous tissue neoplasm (HP:0012316) | 1.73010311 |
| 166 | Abnormality of the calcaneus (HP:0008364) | 1.72355043 |
| 167 | Nausea (HP:0002018) | 1.72198432 |
| 168 | Dry hair (HP:0011359) | 1.72085892 |
| 169 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.71801213 |
| 170 | Microtia (HP:0008551) | 1.71581153 |
| 171 | Septate vagina (HP:0001153) | 1.71324234 |
| 172 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.70757826 |
| 173 | Hyperalaninemia (HP:0003348) | 1.68778182 |
| 174 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68778182 |
| 175 | Abnormality of alanine metabolism (HP:0010916) | 1.68778182 |
| 176 | Short thumb (HP:0009778) | 1.68056637 |
| 177 | Embryonal renal neoplasm (HP:0011794) | 1.67939429 |
| 178 | Hypochromic anemia (HP:0001931) | 1.67837865 |
| 179 | Mucosal telangiectasiae (HP:0100579) | 1.67782936 |
| 180 | Amaurosis fugax (HP:0100576) | 1.67631231 |
| 181 | Bowel diverticulosis (HP:0005222) | 1.67598195 |
| 182 | Aplasia involving forearm bones (HP:0009822) | 1.67041422 |
| 183 | Absent forearm bone (HP:0003953) | 1.67041422 |
| 184 | Urticaria (HP:0001025) | 1.66796931 |
| 185 | Recurrent bacterial skin infections (HP:0005406) | 1.61420193 |
| 186 | Leukopenia (HP:0001882) | 1.61078946 |
| 187 | Breast hypoplasia (HP:0003187) | 1.61022565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 9.47375732 |
| 2 | ZAK | 6.11001082 |
| 3 | CDC7 | 3.44578936 |
| 4 | VRK1 | 3.34249388 |
| 5 | STK4 | 3.15473041 |
| 6 | RPS6KA5 | 2.96063532 |
| 7 | MST4 | 2.66950919 |
| 8 | MAP3K10 | 2.62645674 |
| 9 | RIPK4 | 2.41418705 |
| 10 | CDK9 | 2.17308269 |
| 11 | EEF2K | 2.10732768 |
| 12 | NEK2 | 2.04649956 |
| 13 | SCYL2 | 2.00664896 |
| 14 | BTK | 1.88766767 |
| 15 | BMX | 1.78202175 |
| 16 | CDK12 | 1.74262321 |
| 17 | BUB1 | 1.70413445 |
| 18 | PKN2 | 1.69566464 |
| 19 | SRPK1 | 1.69287162 |
| 20 | CHEK2 | 1.68253344 |
| 21 | AURKB | 1.65586454 |
| 22 | MAP3K8 | 1.60212838 |
| 23 | WEE1 | 1.55764576 |
| 24 | PIM1 | 1.54776740 |
| 25 | SYK | 1.41289683 |
| 26 | TEC | 1.41060303 |
| 27 | RPS6KB2 | 1.39730118 |
| 28 | TTK | 1.34394498 |
| 29 | SMG1 | 1.27880660 |
| 30 | EPHA2 | 1.26613273 |
| 31 | BLK | 1.25612470 |
| 32 | DYRK3 | 1.14701666 |
| 33 | PASK | 1.11743512 |
| 34 | ATR | 1.09276490 |
| 35 | PIM2 | 1.08952688 |
| 36 | PKN1 | 1.06099074 |
| 37 | PLK1 | 1.05812308 |
| 38 | CDK4 | 1.05148928 |
| 39 | DAPK3 | 0.99260361 |
| 40 | TTN | 0.98349322 |
| 41 | AURKA | 0.97964017 |
| 42 | PIK3CG | 0.97914552 |
| 43 | CSF1R | 0.97707223 |
| 44 | GRK6 | 0.95614612 |
| 45 | NEK1 | 0.91761053 |
| 46 | ILK | 0.84045060 |
| 47 | EIF2AK1 | 0.83837145 |
| 48 | BMPR2 | 0.83371938 |
| 49 | CCNB1 | 0.82197706 |
| 50 | FLT3 | 0.80739200 |
| 51 | MELK | 0.80250309 |
| 52 | CHEK1 | 0.80241897 |
| 53 | STK24 | 0.79981037 |
| 54 | MYLK | 0.79705524 |
| 55 | STK10 | 0.75135865 |
| 56 | ATM | 0.75077376 |
| 57 | PLK3 | 0.72787379 |
| 58 | LYN | 0.72428747 |
| 59 | CDK6 | 0.71833844 |
| 60 | ACVR1B | 0.71514858 |
| 61 | CAMK1D | 0.71214526 |
| 62 | PTK2B | 0.66463183 |
| 63 | CDK2 | 0.66443081 |
| 64 | IKBKB | 0.65908401 |
| 65 | AKT2 | 0.63763053 |
| 66 | TAF1 | 0.62820198 |
| 67 | HCK | 0.62200802 |
| 68 | GRK5 | 0.61436294 |
| 69 | CDK7 | 0.61385980 |
| 70 | BRD4 | 0.60871537 |
| 71 | MAPK11 | 0.59998109 |
| 72 | FGFR2 | 0.59151775 |
| 73 | IRAK4 | 0.58827990 |
| 74 | MAP2K3 | 0.58193726 |
| 75 | LATS1 | 0.58047733 |
| 76 | ARAF | 0.57534672 |
| 77 | BRAF | 0.56014491 |
| 78 | MAPKAPK3 | 0.54965859 |
| 79 | STK3 | 0.54615681 |
| 80 | KSR1 | 0.54213245 |
| 81 | CDK1 | 0.53336658 |
| 82 | DYRK1B | 0.52426336 |
| 83 | NME2 | 0.51286634 |
| 84 | CSNK1D | 0.50722574 |
| 85 | ICK | 0.50210812 |
| 86 | LRRK2 | 0.48332462 |
| 87 | BRSK2 | 0.47817886 |
| 88 | TRIB3 | 0.47072882 |
| 89 | PRKAA1 | 0.45879842 |
| 90 | MTOR | 0.45642577 |
| 91 | NEK9 | 0.45217095 |
| 92 | PBK | 0.43429468 |
| 93 | TESK2 | 0.43122594 |
| 94 | FRK | 0.42838180 |
| 95 | TGFBR1 | 0.42108331 |
| 96 | CLK1 | 0.38547097 |
| 97 | PTK6 | 0.38510996 |
| 98 | ZAP70 | 0.38475490 |
| 99 | BRSK1 | 0.37689970 |
| 100 | CDK8 | 0.36206363 |
| 101 | STK16 | 0.35959654 |
| 102 | IRAK3 | 0.35946259 |
| 103 | RAF1 | 0.34885518 |
| 104 | PRKDC | 0.34767672 |
| 105 | RET | 0.33973839 |
| 106 | MARK3 | 0.33347730 |
| 107 | PAK4 | 0.32571014 |
| 108 | PDGFRA | 0.32310000 |
| 109 | LMTK2 | 0.31538485 |
| 110 | PLK4 | 0.31446949 |
| 111 | TNK2 | 0.30139371 |
| 112 | MAP4K1 | 0.29550051 |
| 113 | EIF2AK3 | 0.28852958 |
| 114 | PAK2 | 0.28187441 |
| 115 | ROCK1 | 0.26694452 |
| 116 | MAPK14 | 0.25757937 |
| 117 | MKNK1 | 0.25516804 |
| 118 | PAK1 | 0.25487714 |
| 119 | PRKCD | 0.24937470 |
| 120 | ALK | 0.24526531 |
| 121 | BCKDK | 0.23744754 |
| 122 | FGR | 0.23352989 |
| 123 | AKT1 | 0.21940014 |
| 124 | EIF2AK2 | 0.20037173 |
| 125 | JAK2 | 0.19725351 |
| 126 | PDK1 | 0.19702220 |
| 127 | MAPK12 | 0.18526158 |
| 128 | KDR | 0.18383839 |
| 129 | TAOK3 | 0.18256719 |
| 130 | FGFR1 | 0.18148153 |
| 131 | MET | 0.16385431 |
| 132 | CSNK2A2 | 0.16285168 |
| 133 | MAPKAPK5 | 0.16140707 |
| 134 | RPS6KB1 | 0.15276702 |
| 135 | EPHA3 | 0.15105009 |
| 136 | NUAK1 | 0.14379340 |
| 137 | PRKACG | 0.13910366 |
| 138 | DAPK1 | 0.13901012 |
| 139 | FES | 0.13821954 |
| 140 | TSSK6 | 0.13808426 |
| 141 | MAP2K7 | 0.13793409 |
| 142 | PRKCI | 0.13566660 |
| 143 | NLK | 0.13201415 |
| 144 | RPS6KA3 | 0.13049593 |
| 145 | PRKCQ | 0.13028209 |
| 146 | CSNK1G3 | 0.12672421 |
| 147 | TRPM7 | 0.12564973 |
| 148 | MAP2K1 | 0.12373215 |
| 149 | GSK3B | 0.11950937 |
| 150 | ITK | 0.11913130 |
| 151 | RIPK1 | 0.11771810 |
| 152 | RPS6KA4 | 0.11752178 |
| 153 | CSNK1A1L | 0.10431640 |
| 154 | MAPK1 | 0.10388298 |
| 155 | MKNK2 | 0.09870189 |
| 156 | MAPK9 | 0.09488511 |
| 157 | MAPK8 | 0.09397303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Alcoholism_Homo sapiens_hsa05034 | 6.70446042 |
| 2 | Viral carcinogenesis_Homo sapiens_hsa05203 | 3.43919557 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.91400663 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.43799959 |
| 5 | Cell cycle_Homo sapiens_hsa04110 | 2.00133439 |
| 6 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 11.6455333 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.90069162 |
| 8 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.72017267 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.65110516 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59581988 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.53063112 |
| 12 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.51279725 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.50920497 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 1.49897773 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.48562618 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46335785 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40757413 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 1.36771429 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.32601069 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.27639014 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.26120696 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18585900 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13530074 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08620150 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.05030409 |
| 26 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98745789 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 0.98365662 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90271234 |
| 29 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.86906908 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78822082 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77139065 |
| 32 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76379392 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73418510 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72266701 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70469108 |
| 36 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66443783 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65977236 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65761266 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63785660 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 0.60491999 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56944930 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 0.56473368 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 0.54080590 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54075415 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53311110 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52506514 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47111924 |
| 48 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46264777 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46121849 |
| 50 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45570172 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.45094050 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43477221 |
| 53 | Glioma_Homo sapiens_hsa05214 | 0.43107663 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42344410 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41738190 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41624653 |
| 57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41619541 |
| 58 | Gap junction_Homo sapiens_hsa04540 | 0.40210258 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39960763 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 0.39537687 |
| 61 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38479149 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38477214 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38405912 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37902368 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36244888 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35963122 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.35926031 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35229866 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.34527782 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.33905717 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32963673 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32562750 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.32416110 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30652430 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30308715 |
| 76 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30120037 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.28443700 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27817935 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27035804 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27025420 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.26771722 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24983957 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24879260 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.23763524 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23420776 |
| 86 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22529129 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22437123 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.21866804 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21518967 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.21072442 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.20881547 |
| 92 | Adherens junction_Homo sapiens_hsa04520 | 0.20775022 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20273587 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.19771647 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19649110 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.19623094 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19431089 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19061290 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18999841 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.18230848 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.17958584 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17708157 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17078243 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.16984842 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16849614 |
| 106 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16706351 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.16232793 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.15960029 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15821447 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.14954897 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14891531 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13959510 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13866252 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13074089 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.12893460 |
| 116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.12672941 |
| 117 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.12368964 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.12330500 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12195495 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12023304 |
| 121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.11753692 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11726391 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11314325 |
| 124 | Tuberculosis_Homo sapiens_hsa05152 | 0.10091972 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.09837841 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09154854 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.08926952 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08758488 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08734187 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08502321 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.07897699 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.07720172 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.07550924 |
| 134 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06784388 |
| 135 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.06544176 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.06273964 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.05674039 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.05627622 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.05372810 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.04548302 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.04009588 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.03450969 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.03185301 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03065977 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.02819074 |
| 146 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02206784 |

